Anteilseigner
Capital Research & Management Co. (World Investors) (13,60 %) BlackRock Fund Advisors (7,65 %) GIC Pte Ltd. (Investment Management) (6,63 %) Palo Alto Investors LP (5,96 %) The Vanguard Group, Inc. (5,50 %) Franklin Advisers, Inc. (5,36 %) Polar Capital LLP (3,61 %) JPMorgan Investment Management, Inc. (2,91 %) SSgA Funds Management, Inc. (2,87 %) Geode Capital Management LLC (2,19 %) JPMorgan Asset Management (UK) Ltd. (2,16 %) Invesco Advisers, Inc. (1,73 %) Rubric Capital Management LP (1,66 %) CIBC Asset Management, Inc. (1,31 %) Jennison Associates LLC (1,18 %) Walleye Capital LLC (1,11 %) Deerfield Management Co. LP (Private Equity) (0,99 %)
Kontakt
Revance Therapeutics Inc.